Search research articles
Contact Us
Filters
Showing results (41-50 of 85) with videos related to
Page
of 9
Sort By:
Experimental Hematology
|
December 27, 2011
Nicotinamide, a SIRT1 inhibitor, inhibits differentiation and facilitates expansion of hematopoietic progenitor cells with enhanced bone marrow homing and engraftment
Tony Peled, Hadas Shoham, Dorit Aschengrau, et al.
Molecular Cancer Therapeutics
|
February 8, 2014
Combination of imatinib with CXCR4 antagonist BKT140 overcomes the protective effect of stroma and targets CML in vitro and in vivo
Katia Beider, Merav Darash-Yahana, Orly Blaier, et al.
Plos One
|
September 28, 2011
Involvement of CCR6/CCL20/IL-17 axis in NSCLC disease progression
Sophie Kirshberg, Uzi Izhar, Gail Amir, et al.
European Journal of Immunology
|
April 29, 2004
Differential usage of VLA-4 and CXCR4 by CD3+CD56+ NKT cells and CD56+CD16+ NK cells regulates their interaction with endothelial cells
Suzanna Franitza, Valentin Grabovsky, Ori Wald, et al.
Plos One
|
April 3, 2009
Interaction between CXCR4 and CCL20 pathways regulates tumor growth
Katia Beider, Michal Abraham, Michal Begin, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
October 4, 2011
Improvement of CXCR4 tracer specificity for PET imaging
Orit Jacobson, Ido D Weiss, Lawrence P Szajek, et al.
Journal of Hematology & Oncology
|
November 26, 2020
Blocking of Transient Receptor Potential Vanilloid 1 (TRPV1) promotes terminal mitophagy in multiple myeloma, disturbing calcium homeostasis and targeting ubiquitin pathway and bortezomib-induced unfolded protein response
Katia Beider, Evgenia Rosenberg, Valeria Dimenshtein-Voevoda, et al.
Blood
|
May 6, 2003
CXCL12 expression by invasive trophoblasts induces the specific migration of CD16- human natural killer cells
Jacob Hanna, Ori Wald, Debra Goldman-Wohl, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
August 29, 2012
In vitro and in vivo therapeutic efficacy of CXCR4 antagonist BKT140 against human non-small cell lung cancer
Duha Fahham, Ido D Weiss, Michal Abraham, et al.
Research Square
|
March 4, 2025
BKT300: A Novel Anti-Leukemic Small Molecule Targeting the Protein Regulator of Cytokinesis 1 (PRC1) Pathway
Amnon Peled, Michal Abraham, Hanna Wald, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 85) with videos related to
Sort By:
Page
of 9
Experimental Hematology
|
December 27, 2011
Nicotinamide, a SIRT1 inhibitor, inhibits differentiation and facilitates expansion of hematopoietic progenitor cells with enhanced bone marrow homing and engraftment
Tony Peled, Hadas Shoham, Dorit Aschengrau, et al.
Molecular Cancer Therapeutics
|
February 8, 2014
Combination of imatinib with CXCR4 antagonist BKT140 overcomes the protective effect of stroma and targets CML in vitro and in vivo
Katia Beider, Merav Darash-Yahana, Orly Blaier, et al.
Plos One
|
September 28, 2011
Involvement of CCR6/CCL20/IL-17 axis in NSCLC disease progression
Sophie Kirshberg, Uzi Izhar, Gail Amir, et al.
European Journal of Immunology
|
April 29, 2004
Differential usage of VLA-4 and CXCR4 by CD3+CD56+ NKT cells and CD56+CD16+ NK cells regulates their interaction with endothelial cells
Suzanna Franitza, Valentin Grabovsky, Ori Wald, et al.
Plos One
|
April 3, 2009
Interaction between CXCR4 and CCL20 pathways regulates tumor growth
Katia Beider, Michal Abraham, Michal Begin, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
October 4, 2011
Improvement of CXCR4 tracer specificity for PET imaging
Orit Jacobson, Ido D Weiss, Lawrence P Szajek, et al.
Journal of Hematology & Oncology
|
November 26, 2020
Blocking of Transient Receptor Potential Vanilloid 1 (TRPV1) promotes terminal mitophagy in multiple myeloma, disturbing calcium homeostasis and targeting ubiquitin pathway and bortezomib-induced unfolded protein response
Katia Beider, Evgenia Rosenberg, Valeria Dimenshtein-Voevoda, et al.
Blood
|
May 6, 2003
CXCL12 expression by invasive trophoblasts induces the specific migration of CD16- human natural killer cells
Jacob Hanna, Ori Wald, Debra Goldman-Wohl, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
August 29, 2012
In vitro and in vivo therapeutic efficacy of CXCR4 antagonist BKT140 against human non-small cell lung cancer
Duha Fahham, Ido D Weiss, Michal Abraham, et al.
Research Square
|
March 4, 2025
BKT300: A Novel Anti-Leukemic Small Molecule Targeting the Protein Regulator of Cytokinesis 1 (PRC1) Pathway
Amnon Peled, Michal Abraham, Hanna Wald, et al.
Page
of 9